CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $35,023,032
- in 1 filing
- Open-market sales, last 90 days
- $7,011,938
- in 3 filings, $6.7M under 10b5-1 plans
Net +$28,011,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-02 | BATE KENNETH Director | Option exercise 10b5-1 | +11,212 | $105.08 | $1.2M | 12,410 |
| 2024-04-02 | BATE KENNETH Director | Sale 10b5-1 | −1,217 | $243.28 | $296K | 11,193 |
| 2024-04-02 | BATE KENNETH Director | Sale 10b5-1 | −7,048 | $244.27 | $1.7M | 4,145 |
| 2024-04-02 | BATE KENNETH Director | Sale 10b5-1 | −2,080 | $244.97 | $510K | 2,065 |
| 2024-04-02 | BATE KENNETH Director | Sale 10b5-1 | −567 | $246.20 | $140K | 1,498 |
| 2024-04-02 | BATE KENNETH Director | Sale 10b5-1 | −100 | $246.88 | $25K | 1,398 |
| 2024-04-02 | BATE KENNETH Director | Sale 10b5-1 | −193 | $248.49 | $48K | 1,205 |
| 2024-04-02 | BATE KENNETH Director | Sale 10b5-1 | −7 | $249.05 | $2K | 1,198 |
| 2024-04-02 | BATE KENNETH Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −11,212 | 0 | ||
| 2024-04-02 | Daly James M Director | Option exercise 10b5-1 | +10,912 | $105.08 | $1.1M | 12,110 |
| 2024-04-02 | Daly James M Director | Sale 10b5-1 | −842 | $243.26 | $205K | 11,268 |
| 2024-04-02 | Daly James M Director | Sale 10b5-1 | −6,279 | $244.19 | $1.5M | 4,989 |
| 2024-04-02 | Daly James M Director | Sale 10b5-1 | −2,991 | $244.89 | $732K | 1,998 |
| 2024-04-02 | Daly James M Director | Sale 10b5-1 | −557 | $246.30 | $137K | 1,441 |
| 2024-04-02 | Daly James M Director | Sale 10b5-1 | −43 | $247.03 | $11K | 1,398 |
| 2024-04-02 | Daly James M Director | Sale 10b5-1 | −200 | $248.45 | $50K | 1,198 |
| 2024-04-02 | Daly James M Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −10,912 | 0 | ||
| 2024-04-01 | Levy Richard S Director | Option exercise 10b5-1 | +5,000 | $7.36 | $37K | 15,298 |
| 2024-04-01 | Levy Richard S Director | Option exercise 10b5-1 | +6,000 | $111.06 | $666K | 21,298 |
| 2024-04-01 | Levy Richard S Director | Sale 10b5-1 | −4,387 | $255.90 | $1.1M | 16,911 |
Page 34 of 82 · 1,629 trades